BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 20210715)

  • 41. Molecular mechanisms behind clinical benefits of intensive insulin therapy during critical illness: glucose versus insulin.
    Vanhorebeek I; Langouche L
    Best Pract Res Clin Anaesthesiol; 2009 Dec; 23(4):449-59. PubMed ID: 20108584
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Moderate glycemic control safe in critically ill adult burn patients: A 15 year cohort study.
    Stoecklin P; Delodder F; Pantet O; Berger MM
    Burns; 2016 Feb; 42(1):63-70. PubMed ID: 26691869
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intensive insulin therapy in critically ill hospitalized patients: making it safe and effective.
    Klonoff DC
    J Diabetes Sci Technol; 2011 May; 5(3):755-67. PubMed ID: 21722591
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Disglycemia in patients with acute kidney injury in the ICU].
    Fiaccadori E; Sabatino A; Morabito S; Bozzoli L; Donadio C; Maggiore U; Regolisti G
    G Ital Nefrol; 2015; 32(1):. PubMed ID: 25774588
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperglycemia and perioperative glucose management.
    Duncan AE
    Curr Pharm Des; 2012; 18(38):6195-203. PubMed ID: 22762467
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intensive insulin therapy in the intensive care unit: update on clinical impact and mechanisms of action.
    Vanhorebeek I; Langouche L; Van den Berghe G
    Endocr Pract; 2006; 12 Suppl 3():14-22. PubMed ID: 16905512
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative Simulation Study of Glucose Control Methods Designed for Use in the Intensive Care Unit Setting via a Novel Controller Scoring Metric.
    DeJournett J; DeJournett L
    J Diabetes Sci Technol; 2017 Nov; 11(6):1207-1217. PubMed ID: 28637358
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypoglycemia risk: a cause for concern in the intensive care unit hyperglycemia control debate.
    Freire AX; Avecillas JF; Yataco JC; Freire NE
    Crit Care Med; 2007 Apr; 35(4):1222; author reply 1222. PubMed ID: 17413809
    [No Abstract]   [Full Text] [Related]  

  • 49. Intensive insulin protocol implementation and outcomes in the medical and surgical wards at a Veterans Affairs Medical Center.
    Chen HJ; Steinke DT; Karounos DG; Lane MT; Matson AW
    Ann Pharmacother; 2010 Feb; 44(2):249-56. PubMed ID: 20103610
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tight Glycemic Control in Critically Ill Children.
    Agus MS; Wypij D; Hirshberg EL; Srinivasan V; Faustino EV; Luckett PM; Alexander JL; Asaro LA; Curley MA; Steil GM; Nadkarni VM;
    N Engl J Med; 2017 Feb; 376(8):729-741. PubMed ID: 28118549
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Understanding glycemic control in the critically ill: 2011 update.
    Krinsley JS
    Hosp Pract (1995); 2011 Apr; 39(2):47-55. PubMed ID: 21576897
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glucose metabolism and insulin resistance in sepsis.
    Van Cromphaut SJ; Vanhorebeek I; Van den Berghe G
    Curr Pharm Des; 2008; 14(19):1887-99. PubMed ID: 18691100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reducing glycemic variability in intensive care unit patients: a new therapeutic target?
    Egi M; Bellomo R
    J Diabetes Sci Technol; 2009 Nov; 3(6):1302-8. PubMed ID: 20144384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Barriers to glucose control in the intensive care unit.
    Anger KE; Szumita PM
    Pharmacotherapy; 2006 Feb; 26(2):214-28. PubMed ID: 16466326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implementing glucose control protocols in critically ill patients.
    Susla GM
    AACN Adv Crit Care; 2007; 18(1):5-9. PubMed ID: 17284942
    [No Abstract]   [Full Text] [Related]  

  • 56. A Pediatric Intensive Care Unit Bedside Computer Clinical Decision Support Protocol for Hyperglycemia Is Feasible, Safe and Offers Advantages.
    Hirshberg EL; Lanspa MJ; Wilson EL; Sward KA; Jephson A; Larsen GY; Morris AH
    Diabetes Technol Ther; 2017 Mar; 19(3):188-193. PubMed ID: 28248127
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The glycemia threat in sepsis: too high, too low, or too... variable!
    Spapen HD
    Crit Care Med; 2008 Aug; 36(8):2459-60. PubMed ID: 18664802
    [No Abstract]   [Full Text] [Related]  

  • 58. Intensive insulin therapy and mortality in critically ill patients.
    Treggiari MM; Karir V; Yanez ND; Weiss NS; Daniel S; Deem SA
    Crit Care; 2008; 12(1):R29. PubMed ID: 18312617
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Intensive insulin therapy in critically ill patients--contra].
    Marx G; Brunkhorst FM; Reinhart K
    Dtsch Med Wochenschr; 2006 Nov; 131(44):2481. PubMed ID: 17066360
    [No Abstract]   [Full Text] [Related]  

  • 60. Software-guided versus nurse-directed blood glucose control in critically ill patients: the LOGIC-2 multicenter randomized controlled clinical trial.
    Dubois J; Van Herpe T; van Hooijdonk RT; Wouters R; Coart D; Wouters P; Van Assche A; Veraghtert G; De Moor B; Wauters J; Wilmer A; Schultz MJ; Van den Berghe G; Mesotten D
    Crit Care; 2017 Aug; 21(1):212. PubMed ID: 28806982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.